ASCP BB flashcards
ASCP BB · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- ABO gene location
- The ABO gene is located on chromosome 9, while the H gene (FUT1) is on chromosome 19 and determines H antigen expression.
- IgG antibody characteristics
- IgG antibodies are monomeric, cross the placenta, react optimally at 37°C, and are detected by indirect antiglobulin testing; they cause delayed hemolytic reactions.
- Duffy antigen receptor
- The Duffy antigen Fy6 is a receptor for Plasmodium vivax; people with Fy(a-b-) phenotype are resistant to vivax malaria and commonly have West African ancestry.
- Kidd antibody behavior
- Anti-Jka and anti-Jkb often show dosage, can become undetectable over time, and cause delayed hemolytic transfusion reactions with a positive DAT.
- Autocontrol interpretation
- A positive autocontrol with panreactive panel cells suggests an autoantibody; allogeneic adsorption may reveal an underlying clinically significant alloantibody.
- Enzyme treatment effects
- Ficin or papain enhances Rh, Kidd, Lewis, and P1 antigens but denatures Duffy, MNS, and Xga antigens, helping antibody identification.
- DTT treatment effect
- Dithiothreitol denatures Kell, Lutheran, and Dombrock antigens while preserving many other antigens, so it can distinguish these specificities.
- Antibody titration endpoint
- The titer is the reciprocal of the highest serum dilution showing visible reactivity; a higher titer indicates greater antibody concentration.
- Electronic crossmatch criteria
- Electronic crossmatch requires two concordant ABO/Rh typings, no history of clinically significant antibodies, a negative antibody screen, and a validated computer system.
- Immediate-spin crossmatch
- Immediate-spin crossmatch at room temperature primarily detects ABO incompatibility; it does not reliably detect IgG antibodies reactive at 37°C.
- Pretransfusion sample validity
- A pretransfusion sample is generally valid for 3 days if the patient was transfused or pregnant within the prior 3 months; policy may extend it.
- Universal RBC donor
- Group O negative RBCs are the universal RBC donor because they lack A, B, and D antigens; group AB plasma is the universal plasma donor.
- Platelet storage conditions
- Platelets are stored at 20-24°C with continuous agitation for up to 5 days, and the pH must remain at least 6.2 at expiration.
- RBC storage temperature
- RBC units are stored at 1-6°C; additive-solution units may be stored up to 42 days, while CPDA-1 units are stored up to 35 days.
- Irradiation dose
- Cellular blood components are irradiated with 25 Gy (2500 cGy) to the midplane to prevent transfusion-associated graft-versus-host disease.
- Leukoreduction threshold
- Leukoreduction reduces residual white cells to less than 5 x 10^6 per unit, lowering febrile nonhemolytic reactions and cytomegalovirus transmission risk.
- Acute hemolytic reaction signs
- Acute hemolytic transfusion reaction presents with fever, chills, flank pain, hypotension, and hemoglobinuria; the transfusion must be stopped immediately.
- TACO features
- Transfusion-associated circulatory overload causes dyspnea, hypertension, and pulmonary edema within 6 hours; treatment includes oxygen and diuretics.
- TRALI features
- Transfusion-related acute lung injury causes hypoxemia and bilateral infiltrates within 6 hours without volume overload; donor antibodies are often implicated.
- Delayed hemolytic reaction
- Delayed hemolytic transfusion reaction occurs 3-14 days after transfusion with falling hemoglobin, positive DAT, and a new alloantibody.
- RhIG 300 microgram dose
- A 300-microgram dose of Rh immune globulin neutralizes about 15 mL of fetal RBCs or 30 mL of fetal whole blood.
- Kleihauer-Betke test
- The Kleihauer-Betke test detects fetal hemoglobin resistant to acid elution and quantifies fetal-maternal hemorrhage to guide RhIG dosing.
- MCA-PSV anemia threshold
- A fetal middle cerebral artery peak systolic velocity greater than 1.5 multiples of the median suggests moderate to severe fetal anemia.
- ABO HDFN features
- ABO hemolytic disease of the newborn is usually mild, occurs in group O mothers with IgG anti-A or anti-B, and commonly affects A or B infants.
- Donor hemoglobin criteria
- Donor hemoglobin must be at least 12.5 g/dL for women and 13.0 g/dL for men, with a hematocrit of at least 38%.
- NAT window periods
- Nucleic acid testing shortens infectious window periods to about 9-11 days for HIV, 3-7 days for HCV, and 20-25 days for HBV.
- Malaria travel deferral
- A donor who traveled to a malaria-endemic area is deferred for 12 months unless specific exemption criteria are met.
- Confirmed positive donor test
- A confirmed positive infectious disease test requires donor deferral, discard of the unit, and notification or lookback as required.
- Proficiency testing requirement
- Proficiency testing is required for ABO/Rh typing, antibody detection, crossmatch, and infectious disease testing to monitor laboratory performance.
- Competency assessment timing
- Laboratory personnel must have competency assessed before performing patient testing and at least annually thereafter, with records retained.
- CAPA meaning
- Corrective and preventive action addresses root cause, prevents recurrence, and documents effectiveness after a nonconformance or error.
- Computer crossmatch validation
- A computer crossmatch system must be validated before use and must require two ABO typings, a negative screen, and no antibody history.